HeartCore Signs Fifth Go IPO Agreement with SBC Medical Group
NEW YORK and TOKYO, Nov. 23, 2022 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (“HeartCore” or the “Company”), a leading software development company, announced that it has signed an agreement (“Consulting Agreement”) with SBC Medical Group, Inc. (“SBC Medical”), for its fifth Go IPO consulting service within an eight-month period.
As part of the Consulting Agreement, HeartCore will assist SBC Medical in its efforts to go public and list on the Nasdaq Stock Market (“Nasdaq”). Through Go IPO, the Company services clients by assisting throughout the audit and legal firm hiring process, translating requested documents into English, assisting in the preparation of documentation for internal controls required for an initial public offering or de-SPAC, providing general support services, assisting in the preparation of the S-1 or F-1 filing, and more. As compensation for its services, HeartCore expects to generate from SBC Medical an aggregate of $900,000 in initial fees. In addition, HeartCore has received a warrant to acquire 2.7% of SBC Medical’s common stock, on a fully diluted basis.
“Japanese companies continue to express interest in listing on the U.S. markets, and our team has successfully taken advantage of this wave as we executed our fifth Go IPO win of 2022,” said CEO Sumitaka Yamamoto. “Prospective Japanese Go IPO clients have appreciated our expertise in helping private companies kickstart and navigate their capital markets journey with our white glove service and catered consultation, which has resulted in a robust business pipeline for HeartCore.”
About HeartCore Enterprises, Inc.
HeartCore Investor Relations Contact:
Conference Boxed Lunches - For Diamond, Platinum, Super Pass, Exhibitor/Conference, Speaker, Press Pass Holders
IoT Development: Where Experience Counts
How Shifting WAN Strategies Impact Costs and Revenue